What is the EV/FCF ratio for Enanta Pharmaceuticals, Inc. (ENTA)?

The EV/FCF ratio for ENTA stock is N/A.

What is the estimated TTM average EV/FCF ratio for Enanta Pharmaceuticals, Inc. (ENTA)?

The estimated TTM average EV/FCF ratio for ENTA stock is 25.83x.

What is the estimated 3Y average EV/FCF ratio for Enanta Pharmaceuticals, Inc. (ENTA)?

The estimated 3Y average EV/FCF ratio for ENTA stock is 29.11x.

What is the estimated 5Y average EV/FCF ratio for Enanta Pharmaceuticals, Inc. (ENTA)?

The estimated 5Y average EV/FCF ratio for ENTA stock is 25.05x.

Enanta Pharmaceuticals (ENTA) EV/FCF: History & Chart

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T14:16:34.944Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:16:34.944Z.

Quote observation: 2026-10-06T14:15:21.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 350,685,516
Total debt · period ending 2026-06-30: 55,656,000
Cash · period ending 2026-06-30: 33,419,000
TTM free cash flow · period ending 2026-06-30: -36,939,000

FMP input reference: 86fff216fe9f4e43fb815e843488a8aee31e33e8cf855d0ea3412f6f5fc7b913

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

ENTA EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

EV/FCF RATIO AVG TTM

25.83x

EV/FCF RATIO AVG 3Y

29.11x

EV/FCF RATIO AVG 5Y

25.05x

EV/FCF RATIO AVG 10Y

N/A

EV/FCF RATIO AVG 15Y

N/A

EV/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

ENTA Competitors' EV/FCF Ratio

ENTA

Enanta Pharmaceuticals, Inc.

Current

Market Cap

$350.69M

EV/FCF Ratio

N/A

TTM Avg

25.83x

3Y Avg

29.11x

5Y Avg

25.05x

EMBC

Embecta Corp.

vs ENTA

Market Cap

$350.92M

EV/FCF Ratio

9.95x

TTM Avg

9.65x

3Y Avg

69.46x

5Y Avg

48.92x

IRD

Opus Genetics, Inc.

vs ENTA

Market Cap

$352.14M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FENC

Fennec Pharmaceuticals Inc.

vs ENTA

Market Cap

$355.71M

EV/FCF Ratio

N/A

TTM Avg

6.23x

3Y Avg

6.23x

5Y Avg

6.23x

ARTV

Artiva Biotherapeutics, Inc.

vs ENTA

Market Cap

$341.87M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AGEN

Agenus Inc.

vs ENTA

Market Cap

$340.84M

EV/FCF Ratio

N/A

TTM Avg

114948.95x

3Y Avg

114948.95x

5Y Avg

114948.95x

CLPT

ClearPoint Neuro, Inc.

vs ENTA

Market Cap

$336.78M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CGC

Canopy Growth Corporation

vs ENTA

Market Cap

$372.00M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CCCC

C4 Therapeutics, Inc.

vs ENTA

Market Cap

$324.51M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KYTX

Kyverna Therapeutics, Inc.

vs ENTA

Market Cap

$376.63M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Enanta Pharmaceuticals, Inc. (ENTA)	$350.69M	N/A	25.83x	29.11x	25.05x
Embecta Corp. (EMBC)vs ›	$350.92M	9.95x	9.65x	69.46x	48.92x
Opus Genetics, Inc. (IRD)vs ›	$352.14M	N/A	N/A	N/A	N/A
Fennec Pharmaceuticals Inc. (FENC)vs ›	$355.71M	N/A	6.23x	6.23x	6.23x
Artiva Biotherapeutics, Inc. (ARTV)vs ›	$341.87M	N/A	N/A	N/A	N/A
Agenus Inc. (AGEN)vs ›	$340.84M	N/A	114948.95x	114948.95x	114948.95x
ClearPoint Neuro, Inc. (CLPT)vs ›	$336.78M	N/A	N/A	N/A	N/A
Canopy Growth Corporation (CGC)vs ›	$372.00M	N/A	N/A	N/A	N/A
C4 Therapeutics, Inc. (CCCC)vs ›	$324.51M	N/A	N/A	N/A	N/A
Kyverna Therapeutics, Inc. (KYTX)vs ›	$376.63M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio FAQ

What is the EV/FCF ratio for Enanta Pharmaceuticals, Inc. (ENTA)?: The EV/FCF ratio for ENTA stock is N/A.
What is the estimated TTM average EV/FCF ratio for Enanta Pharmaceuticals, Inc. (ENTA)?: The estimated TTM average EV/FCF ratio for ENTA stock is 25.83x.
What is the estimated 3Y average EV/FCF ratio for Enanta Pharmaceuticals, Inc. (ENTA)?: The estimated 3Y average EV/FCF ratio for ENTA stock is 29.11x.
What is the estimated 5Y average EV/FCF ratio for Enanta Pharmaceuticals, Inc. (ENTA)?: The estimated 5Y average EV/FCF ratio for ENTA stock is 25.05x.

ENTA EV/FCF Ratio History

DATE	EV/FCF RATIO
2021-02-09	180.95x
2021-02-08	181.73x
2021-02-05	175.12x
2021-02-04	173.37x
2021-02-03	174.08x
2021-02-02	167.79x
2021-02-01	164.37x
2021-01-29	157.22x
2021-01-28	150.18x
2021-01-27	160.42x
2021-01-26	160.25x
2021-01-25	157.12x
2021-01-22	155.83x
2021-01-21	152.78x
2021-01-20	154.52x
2021-01-19	156.90x
2021-01-15	152.46x
2021-01-14	158.22x
2021-01-13	152.28x
2021-01-12	159.46x
2021-01-11	159.00x
2021-01-08	148.51x
2021-01-07	149.22x
2021-01-06	142.28x
2021-01-05	134.56x
2021-01-04	136.02x
2020-12-31	136.02x
2020-12-30	134.03x
2020-12-29	135.31x
2020-12-28	134.63x
2020-12-24	138.87x
2020-12-23	136.73x
2020-12-22	140.25x
2020-12-21	142.71x
2020-12-18	143.03x
2020-12-17	140.86x
2020-12-16	139.22x
2020-12-15	138.58x
2020-12-14	137.44x
2020-12-11	133.67x
2020-12-10	139.93x
2020-12-09	137.48x
2020-12-08	137.98x
2020-12-07	137.87x
2020-12-04	138.05x
2020-12-03	135.17x
2020-12-02	135.91x
2020-12-01	132.68x
2020-11-30	132.82x
2020-11-27	138.87x
2020-11-25	25.95x
2020-11-24	25.92x
2020-11-23	26.44x
2020-11-20	26.37x
2020-11-19	26.77x
2020-11-18	26.79x
2020-11-17	27.78x
2020-11-16	27.57x
2020-11-13	27.42x
2020-11-12	27.96x
2020-11-11	29.00x
2020-11-10	28.74x
2020-11-09	27.46x
2020-11-06	26.85x
2020-11-05	27.57x
2020-11-04	28.07x
2020-11-03	27.26x
2020-11-02	26.87x
2020-10-30	26.41x
2020-10-29	26.61x
2020-10-28	26.67x
2020-10-27	27.35x
2020-10-26	26.33x
2020-10-23	26.56x
2020-10-22	26.44x
2020-10-21	25.56x
2020-10-20	26.28x
2020-10-19	26.33x
2020-10-16	27.16x
2020-10-15	27.08x
2020-10-14	27.03x
2020-10-13	27.93x
2020-10-12	27.87x
2020-10-09	28.12x
2020-10-08	28.42x
2020-10-07	28.51x
2020-10-06	28.71x
2020-10-05	28.63x
2020-10-02	27.61x
2020-10-01	28.25x
2020-09-30	27.86x
2020-09-29	27.22x
2020-09-28	26.77x
2020-09-25	26.45x
2020-09-24	26.29x
2020-09-23	26.23x
2020-09-22	27.03x
2020-09-21	27.20x
2020-09-18	28.12x
2020-09-17	28.24x
2020-09-16	28.94x
2020-09-15	28.53x
2020-09-14	29.00x
2020-09-11	28.27x
2020-09-10	28.17x
2020-09-09	29.98x
2020-09-08	28.89x
2020-09-04	29.81x
2020-09-03	30.12x
2020-09-02	30.54x
2020-09-01	30.59x
2020-08-31	32.19x
2020-08-28	31.58x
2020-08-27	30.49x
2020-08-26	30.64x
2020-08-25	31.14x
2020-08-24	30.05x
2020-08-21	29.75x
2020-08-20	30.01x
2020-08-19	29.85x
2020-08-18	30.11x
2020-08-17	30.32x
2020-08-14	29.87x
2020-08-13	30.42x
2020-08-12	29.45x
2020-08-11	28.94x
2020-08-10	25.70x
2020-08-07	25.21x
2020-08-06	24.72x
2020-08-05	24.58x
2020-08-04	25.51x
2020-08-03	25.15x
2020-07-31	24.46x
2020-07-30	25.11x
2020-07-29	25.08x
2020-07-28	25.87x
2020-07-27	27.02x
2020-07-24	25.78x
2020-07-23	26.16x
2020-07-22	26.38x
2020-07-21	26.51x
2020-07-20	28.47x
2020-07-17	28.86x
2020-07-16	28.36x
2020-07-15	28.59x
2020-07-14	27.79x
2020-07-13	26.85x
2020-07-10	27.51x
2020-07-09	27.47x
2020-07-08	27.02x
2020-07-07	27.10x
2020-07-06	27.12x
2020-07-02	26.80x
2020-07-01	27.55x
2020-06-30	26.96x
2020-06-29	26.29x
2020-06-26	26.65x
2020-06-25	27.35x
2020-06-24	27.11x
2020-06-23	27.60x
2020-06-22	27.11x
2020-06-19	26.35x
2020-06-18	26.50x
2020-06-17	26.96x
2020-06-16	27.58x
2020-06-15	26.86x
2020-06-12	25.99x
2020-06-11	25.83x
2020-06-10	27.51x
2020-06-09	28.09x
2020-06-08	27.86x
2020-06-05	27.25x
2020-06-04	26.88x
2020-06-03	27.38x
2020-06-02	27.07x
2020-06-01	27.22x
2020-05-29	27.69x
2020-05-28	27.75x
2020-05-27	27.24x
2020-05-26	29.66x
2020-05-22	29.88x
2020-05-21	29.70x
2020-05-20	30.33x
2020-05-19	29.35x
2020-05-18	31.18x
2020-05-15	29.82x
2020-05-14	28.95x
2020-05-13	29.22x
2020-05-12	28.87x
2020-05-11	22.11x
2020-05-08	21.93x
2020-05-07	21.58x
2020-05-06	22.01x
2020-05-05	21.71x
2020-05-04	21.77x
2020-05-01	20.20x
2020-04-30	19.71x
2020-04-29	20.87x
2020-04-28	21.31x
2020-04-27	23.09x
2020-04-24	22.84x
2020-04-23	22.38x
2020-04-22	22.90x
2020-04-21	22.65x
2020-04-20	23.64x
2020-04-17	23.45x
2020-04-16	22.97x
2020-04-15	22.42x
2020-04-14	22.97x
2020-04-13	22.49x
2020-04-09	22.60x
2020-04-08	22.22x
2020-04-07	21.68x
2020-04-06	21.62x
2020-04-03	21.59x
2020-04-02	21.28x
2020-04-01	21.43x
2020-03-31	21.90x
2020-03-30	21.58x
2020-03-27	20.00x
2020-03-26	21.16x
2020-03-25	19.83x
2020-03-24	20.11x
2020-03-23	19.52x
2020-03-20	19.88x
2020-03-19	19.93x
2020-03-18	17.05x
2020-03-17	18.66x
2020-03-16	17.38x
2020-03-13	22.99x
2020-03-12	21.02x
2020-03-11	22.55x
2020-03-10	22.67x
2020-03-09	21.80x
2020-03-06	23.25x
2020-03-05	23.67x
2020-03-04	23.40x
2020-03-03	22.29x
2020-03-02	22.58x
2020-02-28	21.67x
2020-02-27	21.21x
2020-02-26	21.74x
2020-02-25	21.66x
2020-02-24	21.90x
2020-02-21	22.67x
2020-02-20	22.72x
2020-02-19	22.74x
2020-02-18	22.87x
2020-02-14	22.10x
2020-02-13	22.35x
2020-02-12	22.50x
2020-02-11	22.51x
2020-02-10	16.85x
2020-02-07	16.87x
2020-02-06	16.82x
2020-02-05	16.88x
2020-02-04	16.40x
2020-02-03	15.93x
2020-01-31	15.53x
2020-01-30	15.85x

Showing the most recent 260 of 1,714 data points. The chart above shows the full history.

EV/FCF Ratio: N/A

ENTA EV/FCF Ratio Chart

ENTA Average EV/FCF Ratio Chart

ENTA EV/FCF Ratio Metrics

ENTA Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

EV/FCF Ratio FAQ

ENTA EV/FCF Ratio History

Related Metrics